Praxis Precision Medicines (PRAX) Current Assets (2019 - 2026)

Praxis Precision Medicines' Current Assets history runs 8 years deep, the most recent figure standing at $797.8 million for Q1 2026.

• On a quarterly basis, Current Assets rose 139.16% year-over-year to $797.8 million in Q1 2026; TTM through Mar 2026 was $797.8 million, a 139.16% increase from a year earlier, with the FY2025 full-year figure at $610.9 million, up 51.08% from the prior year.
• Current Assets grew to $797.8 million in Q1 2026 per PRAX's latest filing, from $610.9 million in the prior quarter.
• Across five years, Current Assets topped out at $797.8 million in Q1 2026 and bottomed at $84.9 million in Q4 2023.
• The 5-year median for Current Assets is $234.5 million (2022), against an average of $277.7 million.
• Across the five-year window, Current Assets slumped 61.43% in 2022 and surged 376.4% in 2024, its largest moves.
• Year by year, Current Assets stood at $110.8 million in 2022, then declined by 23.42% to $84.9 million in 2023, then jumped by 376.4% to $404.4 million in 2024, then surged by 51.08% to $610.9 million in 2025, then soared by 30.59% to $797.8 million in 2026.
• Per Business Quant, the three latest PRAX Current Assets figures stand at $797.8 million (Q1 2026), $610.9 million (Q4 2025), and $273.8 million (Q3 2025).